chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report received from a health care professional via Health Authority on 05 Jan 2010: This child was vaccinated with Influenza virus vaccine (manufacturer unknown) (batch number unknown), dose: 1 (unit not specified), intramuscularly, for immunisation on 08 Dec 2009. On 09 Dec 2009 the patient experienced chest discomfort, dyspnoea, headache and numbness. The electroencephalography of the patient was abnormal. The outcomes of the events were not reported.
Flu like symptoms and fainting started 12 hours after receiving the vaccine and continued for about 36 hours.
Hives & Welts all over his body. Went to the Doctor 2 times. Treated by steroids and Benadryl.
Swollen scalp feeling, migraines, nausea, vomiting, blurred vision, body aches, muscle pain
Your mammogram performed on 11-18-2021 showed an area that we believe is benign (not cancer). In six (6) months the interpreting radiologist recommends that you have a follow-up study to confirm this area has not changed. A copy of your report has been sent to your doctor
Narrative: Patient was administered second COVID vaccine on 2/18/21 and was found dead at his home on 3/21/21
This spontaneous report was received from a pharmacist referring to a 64 year old female patient. Medical history and concurrent condition were not reported. On 29-JUL-2015, the patient was vaccinated with ZOSTAVAX (lot # K009199; expiration date 27-SEP-2015), dose and route of administration were not reported, to prevent shingles. Concomitant medication was not reported. On 03-AUG-2015, the patient experienced "a mild case of shingles" after receiving ZOSTAVAX, the patient mentioned to the reporter that the shingles were itchy and painful. The reporter stated, the patient was prescribed with an unspecified antiviral medication from an unspecified physician, but the patient declined taking this medication at this time. The outcome of shingles was reported as not recovered/not resolved. The relatedness of the shingles of the ZOSTAVAX was unknown. Additional information has been requested.
pt recvd Typhoid vax & exp flu-like sx for 7 days;
welt on the injection site that was very hot and red; welt on the injection site that was very hot and red; welt on the injection site that was very hot and red; rash all over the body; This is a spontaneous report from a contactable consumer (patient).  A non-pregnant 43-year-old female patient received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: Unknown), via an unspecified route of administration in the left arm on 24Dec2020 (as reported) at 07:45 at 43-years-old at a single dose for COVID-19 immunization.  Medical history included fibromyalgia, hypertension, and shellfish allergy; all from an unknown date and unknown if ongoing. Concomitant medications included escitalopram (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN), ergocalciferol (VIT D); all taken for an unspecified indication from an unspecified date to an unspecified date (received within two weeks of vaccination).  The patient previously took iodine (MANUFACTURER UNKNOWN) and experienced iodine allergy, and codeine (MANUFACTURER UNKNOWN) and experienced codeine allergy; both from an unspecified date to an unspecified date. On 17Dec2020 at 13:15 (as reported), the patient experienced: welt on the injection site that was very hot and red, and rash all over the body. The patient also reported, "I have all the symptoms of COVID-19."  It was unknown if the patient received treatment for the adverse events. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included Rapid test (SARS-CoV-2 test): negative on 04Jan2021. The clinical outcome of the events was not recovered.  The batch/lot numbers for the vaccine, PFIZER-BIONTECH COVID-19 MRNA VACCINE, were not provided and will be requested during follow up.
her pain became worse/more PHN pain/middle of my back to the area under my left breast/increased pain; her post-herpetic neuralgia pain became worse; This spontaneous case was reported by a consumer and describes the occurrence of POST HERPETIC NEURALGIA (her post-herpetic neuralgia pain became worse) and PAIN (her pain became worse/more PHN pain/middle of my back to the area under my left breast/increased pain) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 025A21A) for COVID-19 vaccination.     No specified medical history has been reported.  Concurrent medical conditions included Osteoarthritis since 01-Jan-1986, Post herpetic neuralgia (increased pain) since 14-Apr-2017 and Food allergy (Avocado, banana, pineapple). Concomitant products included AMLODIPINE BESILATE (AMLODIL [AMLODIPINE BESILATE]) for Blood pressure, METOPROLOL SUCCINATE (TOPROL XL) for Blood pressure high, APIXABAN (ELIQUIS) from 02-Jan-2019 to an unknown date for Heartbeats skipped.   On 11-Feb-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Jan-2021, the patient experienced POST HERPETIC NEURALGIA (her post-herpetic neuralgia pain became worse). On an unknown date, the patient experienced PAIN (her pain became worse/more PHN pain/middle of my back to the area under my left breast/increased pain). At the time of the report, POST HERPETIC NEURALGIA (her post-herpetic neuralgia pain became worse) and PAIN (her pain became worse/more PHN pain/middle of my back to the area under my left breast/increased pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient had experienced significantly more post-herpetic neuralgia pain, which was radiating from middle of the back to the area under left breast.  Treatment medication was not provided. AREDs2 was used two per day   Most recent FOLLOW-UP information incorporated above includes: On 15-Sep-2021: Follow-up received contains additional Significant Follow up reporter details updated, patient detail updated,medical history updated,product detail updated,concomitant coded
Redness and warmth 3 inches below injection site. Began 2/20/21 and has not gone away yet 2/22/2021
Really sick; Muscle pain; Chills; He was really tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A 40 year-old male patient received bnt162b2 (BNT162B2), administered in arm left (Lot number: EW0198) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "Really sick"; MYALGIA (non-serious), outcome "unknown", described as "Muscle pain"; CHILLS (non-serious), outcome "unknown", described as "Chills"; FATIGUE (non-serious), outcome "unknown", described as "He was really tired". Therapeutic measures were taken as a result of illness, myalgia, chills, fatigue.  Additional information: Patient's wife was asking if he should proceed with getting the second dose, he still doesn't have any schedule for the second dose. Treatment with Ibuprofen and Tylenol was taken. However after getting the first dose her husband was really sick and experiencing muscle pain and chills for 15 days now. Now, they are asking if he should proceed with getting the second dose, he still doesn't have any schedule for the second dose. The patient was 3 to 4 times a day but sometimes he took the ibuprofen and sometimes he took the Tylenol.  No follow-up attempts are possible. No further information is expected.
One hour after the shot had been administered, the vaccine site intermittently became itchy then sore. Two hours after being given the shot I experienced diarrhea, shaking, nausea and cramping. About 4 hours after, I became fatigued, with muscles aches and slight dizziness.
c/o of itching at the site of injection immediatatley after injection. 1 hour later: c/o headache, numbing at mouth/lips, pale progress to thighness in chest and nausea
Awakened not feeling well, worsened over the course of the day. Reports massive headache, severe nausea and vomiting, continual swelling of arm with severe redness, hot to touch and pain with red bumps inside red area and one sole blister near the center. Patient states administrator did NOT cleanse the administration site with anything prior to giving her the vaccine.
Patient received the vaccine on 5/28/21 and called 6/4/21 because she developed a red rash around injection site today. She also stated that she feels itchy all over.
2 days after getting first dose of Pfizer COVID vaccine, patient developed shortness of breath at night when trying to lay flat. Initially attributed to anxiety or possibly asthma and so did not seek care until 9 days later. Continues to report shortness of breath when laying flat, chest tightness, occasional chest pain with radiation to back. Pain improves with sitting forward. No dyspnea on exertion.
Case number PHEH2014US021201 is an initial spontaneous report received from a healthcare professional on 21 Oct 2014, and with a follow-up received from a healthcare professional on 01 Dec 2014. This case refers to a 17 year old male patient. Past medical history and concomitant medication were not reported. He was vaccinated with an expired dose of MENVEO (batch number: A13017 and expiry date: not reported), at a dose of 0.5 ml intramuscularly into left arm on11 Oct 2014 at approximately 09:30 AM. It was reported that the patient received MENVEO 14 days after expiry date. No adverse event was reported following this administration error. Follow-up received from a healthcare professional on 01 Dec 304: Patients demographics (weight and height), vaccination details (site and time) were updated.
Pt presented 5-16-11 reporting that evening after receiving vaccine (6-13-06), arm swollen and pain in arm & "throughout body". "My body was paralyzed." Also c/o weakness and shortness of breath. No documentation of adverse reaction when pt. returned 6-16-06 for MMR.
According to patient, who called the office approximately 3 hours after receiving the vaccine, he broke out in hives on extremities and face and experienced wheezing.  He took BENADRYL which provided relief.  He was counseled to go to the emergency room anyway.
a day & 1/2 post vax pt was sleeping, fussed, grunted, turned grey, stopped breathing;did mouth to mouth;stayed in hosp;3 days;
Severe back pain/ache at bottom right side of back  Came on sudddnly the next day and lasted 2 days subsided after second day. Had to take several ibuprofen and aleve to preform work and had to use heating pad at home
headaches; dizziness; tiredness; fever; aches; nausea; worsening of a preexistent ear problem; anxiety; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches) and DIZZINESS (dizziness) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headaches) (seriousness criterion medically significant), DIZZINESS (dizziness) (seriousness criterion medically significant), FATIGUE (tiredness), PYREXIA (fever), PAIN (aches), NAUSEA (nausea), EAR DISORDER (worsening of a preexistent ear problem) and ANXIETY (anxiety). At the time of the report, HEADACHE (headaches), DIZZINESS (dizziness), FATIGUE (tiredness), PYREXIA (fever), PAIN (aches), NAUSEA (nausea), EAR DISORDER (worsening of a preexistent ear problem) and ANXIETY (anxiety) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: increased (High) High Blood pressure.         concomitant information was not provided by reporter No treatment information was provided. After 2 weeks he still has the same side effects, fatigue, nausea, headaches; Sender's Comments: This case concerns an 80-year-old, male patient with no relevant medical history reported, who experienced the unexpected events of dizziness, anxiety, pain, blood pressure increased and worsening of preexistant ear disorder and expected events of headache, nausea, fatigue and pyrexia. The events occurred after the third dose of Moderna COVID-19 Vaccine. The rechallenge was not applicable as no further dosing is expected. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.
Initial information received on 19-Jul-2018 regarding an unsolicited valid non-serious case received from a health care professional. This case involves a four-months old patient (gender not reported) who was administered PENTACEL without diluent. This was actual medication error case, as the patient received vaccine without diluent (product preparation error). The patients past medical history, medical treatment(s), vaccination(s) and family history were not provided. No concomitant therapies were reported. On 18-Jul-2018, the patient received a dose of 0.5 ml of suspect PENTACEL lot number, exp date not reported via intramuscular route in the right thigh. It was not reported if the patient experienced any adverse event. Lab data and corrective treatment: not applicable. Outcome: not applicable.
started spotting two days after the second shot; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0164) via an unspecified route of administration in the left arm on 26Apr2021 at 11:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and sulfonamide allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8734) via an unspecified route of administration in the left arm on 05Apr2021 at 11:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 01:00, two days after the second shot, the patient experienced spotting. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of the event spotting was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
I didn't have an adverse event. I only had a sore arm & then got COVID-19 a month later.
pt recv vax 19APR95 & on 20APR95 pt's lt arm started shaking/tremors as pt nursed it lasted maybe 10 seconds; 10mins later lt arm shook again; seen by MD 25APR95 who referred to neurologist; EEG done 9MAY; pt to recv DT only
pt's granddaughter recvd vax but grandfather devel shingles;RN also reported that the granddaughter's younger sister devel eye infect & vesicular rash p/ sister was vaccinated;
This spontaneous report as received from a licensed practical nurse refers to an unspecified number of patients of unknown ages and genders. Information regarding their pertinent medical history, drug reactions/allergies or concurrent conditions were not reported. On 23-MAY-2016, the patients were vaccinated with improperly stored doses of VARIVAX (which had a lot # of L048467 and an expiration date of 02-DEC-2017; however, the doses, dosage numbers, anatomical locations and the routes of administration were not reported). No concomitant therapies were reported. The vaccines experienced a temperature excursion of 5.4 F for a time frame of 30 minutes. Reportedly, no previous temperature excursions had occurred and the aforementioned one was called out due to a data logger. Despite being vaccinated with an improperly stored vaccine, no adverse effects were reported. Notably, no product quality complaint was involved. Additional information has been requested.
Arm swollen, arm pain, all joints hurt, fever, chills, back pain, neck pain, headache.
Severe Headache; Chills; General body aches; This is a spontaneous report from a contactable consumer (the patient). A 27-years-old non-pregnant female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number and expiration date was not reported), via an unspecified route of administration on left arm on 01Feb2021 07:30 AM as a single dose for covid-19 immunization. The Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number and expiration date was not reported), via an unspecified route of administration on left arm on 12Jan2021 as a single dose for covid-19 immunization. The patient medical history included amoxicillin-drug hypersensitivity(allergy) and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.The patient has not received other vaccine in four weeks and no other medications received within 2 weeks of vaccination. On 02Feb2021, the patient experienced severe headache, chills, general body aches. The patient did not receive any treatment. Outcome of the event was recovered in Apr2021.  Information about Lot/Batch number has been requested.
24 hours post vaccination, child noted by parent to have pain, itching, redness to left arm. At 48 hours she presented with red, swollen, hot to touch arm. The follow up received on 8/18/03 states pt required doctor visit, but refused to follow through. So did not go to doctor. Pt did recover.
This spontaneous report as received from a female physician refers to herself. In January 2014 (exact date unspecified, reported as about one year ago) was vaccinated with the first and the second (series of 2 doses) RECOMBIVAX HB injection (5/0.5 mcg/ml, intramuscular, 0.5 ml each). On an unknown date, the patient had no detectable titer after receiving two pediatric doses. The patient stated that no adverse effect was reported. The outcome of the events was not reported. The relatedness between the events and RECOMBIVAX HB was not reported. Additional information has been requested.
Sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore left arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Aug-2021, the patient experienced PAIN IN EXTREMITY (Sore left arm). At the time of the report, PAIN IN EXTREMITY (Sore left arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-325495 (Patient Link).
This is a spontaneous report from a Pfizer-sponsored program. A contactable pharmacist reported for her daughter a female patient of an unspecified age and ethnicity received TRUMENBA, via an unspecified route of administration on 02Aug2017 at single dose for immunization. The patient's medical history and concomitant medications were not reported.  It was reported that the patient got the TRUMENBA shot yesterday and was experiencing extreme muscle pain (Aug2017). It was also reported that her daughter's bones were hurting. Outcome of the adverse events were unknown.
felt itchy all over body after shot.   one week later broke out with hives at the site of the injection.  area at injection red and itchy with lots of bumps.  feel itchy on upper torso as well as upper arms.
Pt. has small red lump with small amount of swelling, warm to touch with no induration. Told pt. to place cold compress on arm and take BENADRYL 2 to 3 time a day per FNP.
Patient presented to ER on 7/1/18 with increasing ecchymoses and petechiae. She was transferred to PICU for severe thrombocytopenia with platelet count of 1K. She received 2 doses of IVIG 1 g/kg and 1 dose of SOLU-MEDROL 4mg/kg, stabilizing and improving platelets to 65K on 7/4/18. She developed fever of 104.8 on day 2 of hospital stay, 5 hours after receiving 2nd dose of IVIG. She was given 1 dose of ROCEPHIN IV. Patient was diagnosed with neutropenia on 7/4/18 and was discharged after discussion with hematology. She followed up with PCP on 7/5/18.
Within 4 hrs of receiving MMR/VZV/ Hep A vaccine fever to 103 degrees persisting x 5 days. No local reaction.
Sore arm day after vaccine administered (07/19/2006) lasted approximately 1 week.  Painful jaw approximately 2 weeks after vaccine administered (beginning approximately August 1) to present.
She got her vaccine, and within a couple of hours had fever, cold chills, achy body, fatigue.  The following week she lost her taste, and ever since she has cold chills constantly, is weak, cannot do anything.  She is light headed, her vision is sometimes blurred and will not go away.  She has been taking Tylenol for fever.  She went to the ER because it was so bad, and they did a CT scan, EKG, chest x-ray for pneumonia, and did blood work.  They could not find anything wrong with her.  She has also been to her doctor who checked her over and could not find anything wrong either.
Pt recvd 3 doses of Engerix-B had nonresponse;